
    
      Reproductive age women diagnosed with POR based on Bologna criteria with a history of at
      least two prior failed intracytoplasmic sperm injection (ICSI) cycle will recruited for the
      study. Antral follicle count (AFC), serum anti-mullerian hormone (AMH), and early follicular
      phase serum follicle stimulating hormone (FSH) levels will be determined at baseline.
      Autologous blood obtained from peripheral vein will be used to prepare PRP following standard
      protocols. PRP injection will be performed under sedation anesthesia, using a 11.8 inch (30
      cm) single lumen 21G needles under transvaginal ultrasound guidance. On the 2 to 4th days of
      the first three menstrual cycles following the procedure, AFC, AMH, and FSH levels will be
      re-assessed. Patients with at least one antral follicle will be started on ovarian
      stimulation for ICSI, followed by embryo transfer. Biomarkers of ovarian reserve (AFC, FSH,
      AMH), and ICSI outcome parameters (number of metaphase II (MII) oocytes, blastocyst embryos,
      fertilization rate, oocyte and embryo quality) will be followed.
    
  